SCHEMBL29350004

SCHEMBL29350004

CCCCCCCCOc1ccc(-c2ccc(C(=O)Oc3ccc(OC(C)CCCCCC)cc3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.59
LMNA P02545 3/20 0.59
NFKB1 P19838 3/20 0.59
NFKB2 Q00653 3/20 0.59
RELA Q04206 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
RARB P10826 4/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2C19 P33261 1/20 0.57
MAPT P10636 3/20 0.52
POLB P06746 1/20 0.52
TSHR P16473 2/20 0.51
TP53 P04637 1/20 0.51
PRSS1 P07477 1/20 0.51
ACR P10323 1/20 0.51
KMT2A Q03164 2/20 0.50
PLA2G4B P0C869 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9513551 1.00 NPC1 (0.59) NPC1LMNANFKB1NFKB2RELA
SCHEMBL14089656 0.96 NPC1 (0.63) NPC1LMNANFKB1NFKB2RELA
SCHEMBL10830591 0.96 NPC1 (0.63) NPC1LMNANFKB1NFKB2RELA
SCHEMBL9175267 0.96 NPC1 (0.63) NPC1LMNANFKB1NFKB2RELA
SCHEMBL10767467 0.95 LMNA (0.54) NPC1LMNANFKB1NFKB2RELA
SCHEMBL10539817 0.95 NPC1 (0.59) NPC1LMNANFKB1NFKB2RELA
SCHEMBL26601901 0.95 NPC1 (0.59) NPC1LMNANFKB1NFKB2RELA
SCHEMBL10719848 0.95 RARB (0.56) NPC1LMNANFKB1NFKB2RELA
SCHEMBL9474994 0.95 NPC1 (0.54) NPC1LMNANFKB1NFKB2RELA
SCHEMBL9474740 0.95 NPC1 (0.54) NPC1LMNANFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4415823-A1 COMPOUNDS AND METHODS FOR TREATING CORONAVIRUSES Clear Creek Bio, Inc. (US) 2024-08-21 EP claimed
CN-117085185-A Biodegradable alloy for improving biocompatibility and degradation controllability and preparation method thereof 上海璞慧医疗器械有限公司 2023-11-21 CN claimed
WO-2023064493-A1 COMPOUNDS AND METHODS FOR TREATING CORONAVIRUSES Clear Creek Bio, Inc. (US) 2023-04-20 WO claimed
WO-2023059583-A1 HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE HALDA THERAPEUTICS OPCO, INC. (US) 2023-04-13 WO claimed
WO-2023059581-A1 HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE HALDA THERAPEUTICS OPCO, INC. (US) 2023-04-13 WO claimed
WO-2023278372-A1 ELECTROACTIVE SPECIES AND METHOD FOR ELECTROCHEMICAL GAS SEPARATION VERDOX, INC. (US) 2023-01-05 WO claimed
CN-109640941-B Odorless and highly stable cosmetic composition 株式会社爱茉莉太平洋 2022-04-22 CN claimed
CN-122095123-A Sputtering target for magnetic recording medium 2026-05-26 CN disclosed
CN-118454683-B In-Co-Zr composite catalyst and preparation method and application thereof SOUTH CHINA AGRICULTURAL UNIVERSITY (CN) 2026-05-26 CN disclosed
EP-3824296-B1 ORAL PHARMACEUTICAL COMPOSITION COMPRISING TESTOSTERONE TRIDECANOATE AND/OR TESTOSTERONE DODECANOATE FOR TREATING LIVER DISEASES LIPOCINE INC (US) 2026-04-01 EP disclosed
EP-4023783-B1 METHOD FOR MANUFACTURING CONTINUOUS CASTING MOLD JFE STEEL CORP (JP) 2026-02-18 EP disclosed
US-12521705-B2 Honeycomb structure and exhaust gas purifying device NGK INSULATORS, LTD. (JP) 2026-01-13 US disclosed
EP-4667081-A1 GAS ADSORPTION/DESORPTION UNIT, GAS ADSORPTION/DESORPTION DEVICE AND METHOD FOR PRODUCING MAGNETIC BODY NGK Insulators, Ltd. (JP) 2025-12-24 EP disclosed
EP-3978575-A1 ANTIFOULING COATING COMPOSITION Nitto Kasei Co., Ltd. (JP) 2022-04-06 EP disclosed
CN-114286718-A Honeycomb structure and exhaust gas purifying device 日本碍子株式会社 2022-04-05 CN disclosed
WO-2022065536-A1 LIGHTWEIGHT MULTI-COMPONENT ALLOY COMPRISING ALUMINUM AND TRANSITION METAL AND PRODUCTION METHOD THEREFOR 엘지전자 주식회사 2022-03-31 WO disclosed
WO-2022059310-A1 SINTERED VALVE SEAT 株式会社リケン 2022-03-24 WO disclosed
US-11246884-B2 Inherently radiopaque polymeric products for embolotherapy RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2022-02-15 US disclosed
CN-113993500-A Cool preparation 德国德之馨香精香料公司 2022-01-28 CN disclosed
CN-108834411-B Polymeric biomaterials derived from phenolic monomers and their medical uses 新泽西鲁特格斯州立大学 2022-01-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11246884-B2 Inherently radiopaque polymeric products for embolotherapy CD47, FGB, ELANE NPC1 3990/4885LMNA 1168/4885NFKB1 3590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.